Fundamental Analysis
30 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -40.3% | -13.2% | 1 / 3 | +1.2% | -5.44 pp | -4.41 pp | +18.4% | 0.08 | 9.24 | 173 | +1,2% | 10,9 | −40,3% | 9.24 | 8.48 | +9,0% |
| Pts | 0 | 0 | 4 | 0 | 0 | 0 | 8 | 12 | 8 | |||||||
Valuation annotation:Price: 32.000 (close price on 2026-10-19)EPS (TTM): 3.462
Financial charts
1.Revenue & growth
VND bn173Q2/26
1.Revenue & growth
VND bn173Q2/26
2.Profit & growth
VND bn11,0Q2/26
3.Profit mix (Penman)
VND bn41,4Q2/26
4.Margins & cost structure
%39.8%Q2/26
5.Returns & cash cycle
% · days22.8%Q2/26
6.Earnings quality & cash
VND bn46,7Q2/26
7.Asset structure
VND bn366Q2/26
8.Funding & debt health
VND bn · times366Q2/26
9.Revenue backlog
VND bn0,52Q2/26
10.Valuation
times · %9,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.155Q2/26
Adjusted EPS growth, latest quarter
-40.2%
Average adjusted EPS growth, 3 quarters
-13.1%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26